151 related articles for article (PubMed ID: 26788508)
41. The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis.
Miao JL; Zhou JH; Cai JJ; Liu RJ
Arch Med Sci; 2020; 16(1):16-26. PubMed ID: 32051701
[TBL] [Abstract][Full Text] [Related]
42. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
[TBL] [Abstract][Full Text] [Related]
43. Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation.
Kwak Y; Nam SK; Seo AN; Kim DW; Kang SB; Kim WH; Lee HS
Pathobiology; 2015; 82(2):76-83. PubMed ID: 26088290
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma.
Schäfer MH; Lingohr P; Sträßer A; Lehnen NC; Braun M; Perner S; Höller T; Kristiansen G; Kalff JC; Gütgemann I
Hum Pathol; 2015 Oct; 46(10):1488-95. PubMed ID: 26239623
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Zhao S; Qiu Z; He J; Li L; Li W
Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
[TBL] [Abstract][Full Text] [Related]
46. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis.
Li X; Zhao H; Gu J; Zheng L
World J Surg Oncol; 2016 Feb; 14(1):38. PubMed ID: 26897036
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.
Behrens C; Lin HY; Lee JJ; Raso MG; Hong WK; Wistuba II; Lotan R
Clin Cancer Res; 2008 Oct; 14(19):6014-22. PubMed ID: 18829480
[TBL] [Abstract][Full Text] [Related]
48. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.
Elbauomy Elsheikh S; Green AR; Lambros MB; Turner NC; Grainge MJ; Powe D; Ellis IO; Reis-Filho JS
Breast Cancer Res; 2007; 9(2):R23. PubMed ID: 17397528
[TBL] [Abstract][Full Text] [Related]
49. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).
Freier K; Schwaenen C; Sticht C; Flechtenmacher C; Mühling J; Hofele C; Radlwimmer B; Lichter P; Joos S
Oral Oncol; 2007 Jan; 43(1):60-6. PubMed ID: 16807070
[TBL] [Abstract][Full Text] [Related]
50. FGFR1 is an important prognostic factor in oral leukoplakia and tongue squamous cell carcinoma.
Mariz BALA; Sales de Sá R; Araújo ALD; Fernandes CIR; Mariano FV; Santos-Silva AR; Lopes MA; Vargas PA; de Almeida OP; Kowalski LP; Jorge J
J Oral Pathol Med; 2023 Feb; 52(2):119-126. PubMed ID: 36565263
[TBL] [Abstract][Full Text] [Related]
51. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
[TBL] [Abstract][Full Text] [Related]
52. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
53. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
[TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
55. MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).
Dworakowska D; Jassem E; Jassem J; Peters B; Dziadziuszko R; Zylicz M; Jakóbkiewicz-Banecka J; Kobierska-Gulida G; Szymanowska A; Skokowski J; Roessner A; Schneider-Stock R
Lung Cancer; 2004 Mar; 43(3):285-95. PubMed ID: 15165086
[TBL] [Abstract][Full Text] [Related]
56. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
57. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.
Dutt A; Ramos AH; Hammerman PS; Mermel C; Cho J; Sharifnia T; Chande A; Tanaka KE; Stransky N; Greulich H; Gray NS; Meyerson M
PLoS One; 2011; 6(6):e20351. PubMed ID: 21666749
[TBL] [Abstract][Full Text] [Related]
58. Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
Malchers F; Dietlein F; Schöttle J; Lu X; Nogova L; Albus K; Fernandez-Cuesta L; Heuckmann JM; Gautschi O; Diebold J; Plenker D; Gardizi M; Scheffler M; Bos M; Seidel D; Leenders F; Richters A; Peifer M; Florin A; Mainkar PS; Karre N; Chandrasekhar S; George J; Silling S; Rauh D; Zander T; Ullrich RT; Reinhardt HC; Ringeisen F; Büttner R; Heukamp LC; Wolf J; Thomas RK
Cancer Discov; 2014 Feb; 4(2):246-57. PubMed ID: 24302556
[TBL] [Abstract][Full Text] [Related]
59. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
60. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]